Antibiotics in the clinical pipeline at the end of 2015
There is growing global recognition that the continued emergence of multidrug-resistant
bacteria poses a serious threat to human health. Action plans released by the World Health …
bacteria poses a serious threat to human health. Action plans released by the World Health …
Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection
Despite the declining trend of Helicobacter pylori (H. pylori) prevalence around the globe,
ongoing efforts are still needed to optimize current and future regimens in view of the …
ongoing efforts are still needed to optimize current and future regimens in view of the …
Structural characterization of the millennial antibacterial (fluoro) quinolones—sha** the fifth generation
The evolution of the class of antibacterial quinolones includes the introduction in therapy of
highly successful compounds. Although many representatives were withdrawn due to …
highly successful compounds. Although many representatives were withdrawn due to …
Newer, Older, and Alternative Agents for the Eradication of Helicobacter pylori Infection: A Narrative Review
GM Buzás, P Birinyi - Antibiotics, 2023 - mdpi.com
Although discovered 40 years ago, Helicobacter pylori infection is still raising diagnostic and
therapeutic problems today. The infection is currently managed based on statements in …
therapeutic problems today. The infection is currently managed based on statements in …
Efficacy of tegoprazan for improving the susceptibility of antimicrobial agents against antibiotic-resistant Helicobacter pylori
Background/Aims Favorable outcomes of potassium-competitive acid blocker (PCAB)-
containing eradication therapy have been reported. In fact, tegoprazan, a recently …
containing eradication therapy have been reported. In fact, tegoprazan, a recently …
Influence of pH on the activity of finafloxacin against extracellular and intracellular Burkholderia thailandensis, Yersinia pseudotuberculosis and Francisella …
Abstract Objectives Burkholderia pseudomallei, Yersinia pestis and Francisella tularensis
are facultative intracellular bacteria causing life-threatening infections. We have (a) …
are facultative intracellular bacteria causing life-threatening infections. We have (a) …
Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication
Abstract Background and Aim Failure of bismuth quadruple therapy for Helicobacter pylori
eradication is frequently observed. To increase the eradication rate, comprehensive …
eradication is frequently observed. To increase the eradication rate, comprehensive …
[HTML][HTML] In Vitro Susceptibility and Synergistic Effect of Bismuth Against Helicobacter pylori
J Woo, CS Bang, JJ Lee, JY Ahn, JM Kim, HY Jung… - Antibiotics, 2024 - mdpi.com
Background/objectives: Bismuth is commonly used in Helicobacter pylori (H. pylori)
eradication therapy. However, few studies have examined the in vitro susceptibility of H …
eradication therapy. However, few studies have examined the in vitro susceptibility of H …
Discovery of a Novel Mutation in DNA Gyrase and Changes in the Fluoroquinolone Resistance of Helicobacter pylori over a 14-Year Period: A Single Center Study in …
SY Rhie, JY Park, TS Shin, JW Kim, BJ Kim, JG Kim - Antibiotics, 2020 - mdpi.com
The efficacy of fluoroquinolone-based eradication therapy largely depends on the
fluoroquinolone resistance of H. pylori. The aim of this study was to investigate the changes …
fluoroquinolone resistance of H. pylori. The aim of this study was to investigate the changes …
Fluoroquinolone and Rifabutin-Containing Therapy
JW Lee - Helicobacter pylori, 2024 - Springer
Fluoroquinolone-containing therapy and rifabutin-containing therapy are regimens which
use proton pump inhibitor and amoxicillin as it is in clarithromycin-containing triple therapy …
use proton pump inhibitor and amoxicillin as it is in clarithromycin-containing triple therapy …